Streetwise Reports (11/14/2025)
This new designation is expected to boost these two segments of the mining industry in the U.S. and potentially allied countries. Keep reading to learn more about three companies that could benefit: Regency Silver Corp. (RSMX:TSX.V; RSMXF:OTCQB), Dolly Varden Silver Corp. (DV:TSX.V; DVS:NYSEA; DVQ:FSE) and Silver North Resources Ltd. (SNAG:TSX.V; TARSF:OTCQB). Streetwise Reports (11/14/2025)
Avidity Biosciences Inc. (RNA:NASDAQ) reported Q3 results alongside news of its US$12 billion acquisition by Novartis. The deal comes as three RNA drugs approach major regulatory filings through 2026. Streetwise Reports (11/13/2025)
aTyr Pharma Inc. (ATYR:NASDAQ) is seeking regulatory clarity following mixed Phase 3 results for its lead candidate efzofitimod in pulmonary sarcoidosis. The company expects feedback from the FDA in the first quarter of 2026 to help determine a potential path forward.